| Issue Date | Title | Author(s) |
| Apr-2020 | Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors | Wang, Zhijie; Duan, Jianchun; Wang, Guoqiang; Zhao, Jing; Xu, Jiachen; Han, Jiefei; Zhao, Zhengyi; Zhao, Jun; Zhu, Bo; Zhuo, Minglei; Sun, Jianguo; Bai, Hua; Wan, Rui; Wang, Xin; Fei, Kailun; Wang, Shuhang; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Huang, Depei; Qi, Chuang; Gao, Chan; Bai, Yuezong; Dong, Hua; Xiong, Lei; Tian, Yanhua; Wang, Di; Xu, Chunwei; Wang, Wenxian; Li, Junling; Hu, Xingsheng; Cai, Shangli; Wang, Jie |
| 2019 | Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel | Wang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo; Wang, Qiming; Bai, Hua; Han, Jiefei; Tian, Yanhua; Lu, Jing; Xu, Tongfu; Zhao, Xiaochen; Wang, Guoqiang; Cao, Xinkai; Li, Fugen; Wang, Dalei; Chen, Yuejun; Bai, Yuezong; Zhao, Jing; Zhao, Zhengyi; Zhang, Yuzi; Xiong, Lei; He, Jie; Gao, Shugeng; Wang, Jie |
| 2019 | Comprehensive immune transcriptomic subtypes of colorectal cancer for development of precision immunotherapy. | Jing, Zhou; Guo, Xueguang; Zhao, Jing; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Cai, Shangli; Zhu, Haitao |
| 6-Jul-2023 | Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma | Mao, Guangxian; Yang, Dongyong; Liu, Bin; Zhang, Yu; Ma, Sijia; Dai, Shang; Wang, Guoqiang; Tang, Wenxiang; Lu, Huafei; Cai, Shangli; Zhu, Jialiang; Yang, Huaping |
| Sep-2024 | Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG) | Jin, Yichen; Mu, Wei; Shi, Yezhen; Qi, Qingyi; Wang, Wenxiang; He, Yue; Sun, Xiaoran; Yang, Bo; Cui, Peng; Li, Chengcheng; Liu, Fang; Liu, Yuxia; Wang, Guoqiang; Zhao, Jing; Zhang, Yuzi; Zhang, Shuaitong; Cao, Caifang; Sun, Chao; Hong, Nan; Cai, Shangli; Tian, Jie; Yang, Fan; Chen, Kezhong |
| 20-May-2021 | Identification of predictive biomarker for immunotherapy by associating with CD8+T cell Infiltration in lung adenocarcinoma. | Xing, Puyuan; Li, Teng; Wang, Han; Yang, Lin; Wang, Guoqiang; Cai, Shangli; Li Junling |
| 20-May-2021 | Identification of TGFBR2 mutation as a negative predictor of immunotherapy in NSCLC. | Li, Teng; Wang, Han; Xu, Jiachen; Li, Chengcheng; Zhang, Yudong; Wang, Guoqiang; Cai, Shangli; Li Junling; Wang, Zhijie |
| 2018 | Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence | Si, Tianmei; Li, Nan; Lu, Huafei; Cai, Shangli; Zhuo, Jianmin; Correll, Christoph U.; Zhang, Lili; Feng, Yu |
| 2019 | An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes | Cheng, Zhang; Yuan, Yanbo; Han, Xue; Yang, Lei; Cai, Shangli; Yang, Fude; Lu, Zheng; Wang, Chuanyue; Deng, Hong; Zhao, Jingping; Xiang, Yutao; Correll, Christoph U.; Yu, Xin |
| 1-Jun-2024 | Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk stage II-III gastrointestinal stromal tumor | Gao, Zhidong; Cheng, Baosen; Bao, Yudi; Cui, Peng; Du, Haiwei; Fan, Xuning; Peng, Di; Yang, Shuya; Wu, Xin; Zhao, Dongbing; Xing, Zhaodong; Cao, Feng; Zhang, Wei; Li, Bing; Li, Chengcheng; Zhang, Yuzi; Wang, Guoqiang; Cai, Shangli; Ye, Yingjiang |
| Aug-2021 | TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer | Li, Teng; Wang, Han; Xu, Jiachen; Li, Chengcheng; Zhang, Yudong; Wang, Guoqiang; Liu, Yutao; Cai, Shangli; Fang, Wenfeng; Li, Junling; Wang, Zhijie |
| 2019 | Tumor mutation burden and immunogenicity in gastric cancer with HER2 alterations. | Wei, Bo; Xing, Xiaojing; Li, Ziyu; Han, Quanli; Hao, Yingxue; Zhou, Jing; Zhang, Yuzi; Zhao, Jing; Cai, Shangli; Gu, Yanhong; Chen, Tufeng |
| 19-Dec-2023 | Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma | Duan, Jianchun; Zhang, Yun; Chen, Ran; Liang, Liang; Huo, Yi; Lu, Shun; Zhao, Jun; Hu, Chunhong; Sun, Yuping; Yang, Kunyu; Chen, Mingwei; Yu, Yan; Ying, Jianming; Huang, Ruiqi; Ma, Xiaopeng; Leaw, Shiangjiin; Bai, Fan; Shen, Zhirong; Cai, Shangli; Gao, Daming; Wang, Jie; Wang, Zhijie |
| 19-Dec-2023 | Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma | Duan, Jianchun; Zhang, Yun; Chen, Ran; Liang, Liang; Huo, Yi; Lu, Shun; Zhao, Jun; Hu, Chunhong; Sun, Yuping; Yang, Kunyu; Chen, Mingwei; Yu, Yan; Ying, Jianming; Huang, Ruiqi; Ma, Xiaopeng; Leaw, Shiangjiin; Bai, Fan; Shen, Zhirong; Cai, Shangli; Gao, Daming; Wang, Jie; Wang, Zhijie |
| Mar-2020 | Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer A Systematic Review and Meta-analysis | Duan, Jianchun; Cui, Longgang; Zhao, Xiaochen; Bai, Hua; Cai, Shangli; Wang, Guoqiang; Zhao, Zhengyi; Zhao, Jing; Chen, Shiqing; Song, Jia; Qi, Chuang; Wang, Qing; Huang, Mengli; Zhang, Yuzi; Huang, Depei; Bai, Yuezong; Sun, Feng; Lee, J. Jack; Wang, Zhijie; Wang, Jie |
